Alpha 2.0
Login Register
» Articles » PMID: 2860942

Which Component of Sulphasalazine is Active in Rheumatoid Arthritis?

Overview
Journal Br Med J (Clin Res Ed)
Specialty General Medicine
Date 1985 May 25
PMID 2860942
Citations 35
Authors
T Pullar
J A Hunter
H A Capell
Affiliations
Soon will be listed here.
Abstract

Sulphasalazine is known to be effective as a second line agent in the treatment of rheumatoid arthritis. The two chemical constituents of sulphasalazine (sulphapyridine and 5-aminosalicylic acid) were assessed separately in the treatment of rheumatoid arthritis. Over 24 weeks sulphapyridine showed a pronounced second line effect comparable with sulphasalazine and with a similar toxicity profile, whereas 5-aminosalicylic acid showed only a weak first line effect. Thus sulphapyridine appears to be the active moiety responsible for the second line effect of sulphasalazine in rheumatoid arthritis. The efficacy of the antibacterial component of sulphasalazine yet again permits speculation about the role of a bacterial pathogen in the aetiopathogenesis of rheumatoid disease.

Citing Articles

Gut microbiota and rheumatoid arthritis: From pathogenesis to novel therapeutic opportunities.

Zhao T, Wei Y, Zhu Y, Xie Z, Hai Q, Li Z Front Immunol. 2022; 13:1007165.

PMID: 36159786 PMC: 9499173. DOI: 10.3389/fimmu.2022.1007165.

Usefulness of sulfasalazine for patients with refractory-ulcerative colits.

Yoshino T, Sono M, Yazumi S BMJ Open Gastroenterol. 2016; 3(1):e000103.

PMID: 27648296 PMC: 5013332. DOI: 10.1136/bmjgast-2016-000103.

Molecular Insight into Gut Microbiota and Rheumatoid Arthritis.

Wu X, He B, Liu J, Feng H, Ma Y, Li D Int J Mol Sci. 2016; 17(3):431.

PMID: 27011180 PMC: 4813281. DOI: 10.3390/ijms17030431.

Antibiotics for the treatment of rheumatoid arthritis.

Ogrendik M Int J Gen Med. 2014; 7:43-7.

PMID: 24403843 PMC: 3883615. DOI: 10.2147/IJGM.S56957.

A yeast-based screen reveals that sulfasalazine inhibits tetrahydrobiopterin biosynthesis.

Chidley C, Haruki H, Pedersen M, Muller E, Johnsson K Nat Chem Biol. 2011; 7(6):375-83.

PMID: 21499265 DOI: 10.1038/nchembio.557.

References
1.
Pullar T, Capell H . Sulphasalazine: a 'new' antirheumatic drug. Br J Rheumatol. 1984; 23(1):26-34. DOI: 10.1093/rheumatology/23.1.26. View
2.
Med M . Prenatal development of lumbar intervertebral articulation. Folia Morphol (Praha). 1982; 30(3):285-90. View
3.
Sinclair R, Duthie J . Salazopyrin in the Treatment of Rheumatoid Arthritis. Ann Rheum Dis. 1949; 8(3):226-31. PMC: 1030728. DOI: 10.1136/ard.8.3.226. View
4.
Dixon J, Bird H, Pickup M, WRIGHT V . A human model screening system for the detection of specific antirheumatic activity. Semin Arthritis Rheum. 1982; 12(2):185-90. DOI: 10.1016/0049-0172(82)90059-2. View
5.
MCCONKEY B, Amos R, Durham S, Forster P, Hubball S, Walsh L . Sulphasalazine in rheumatoid arthritis. Br Med J. 1980; 280(6212):442-4. PMC: 1600457. DOI: 10.1136/bmj.280.6212.442. View